tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Emma Nealon, 13 are a BUY (100%).
Analyst Emma Nealon, carries an average stock price target met ratio of 43.75% that have a potential upside of 65.95% achieved within 258 days. Previously, Emma Nealon worked at CANTOR FITZGERALD.
Emma Nealon’s has documented 34 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on EQ, Equillium at 24-Mar-2023.
Analyst best performing recommendations are on EQ (EQUILLIUM).
The best stock recommendation documented was for EQ (EQUILLIUM) at 3/24/2023. The price target of $2.8 was fulfilled within 333 days with a profit of $2.07 (283.56%) receiving and performance score of 8.52.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Jun-2021
$20
$-0.01 (-0.05%)
$40
4 years 1 months 10 days ago
(02-Sep-2022)
1/2 (50%)
$0.02 (0.10%)
41
Buy Since 17-Feb-2021
$49
4 years 1 months 10 days ago
(02-Sep-2022)
0/3 (0%)
$39.17 (398.47%)
Buy Since 08-Sep-2020
$20
$-0.01 (-0.05%)
$53
4 years 1 months 10 days ago
(02-Sep-2022)
1/4 (25%)
$0.02 (0.10%)
41
Buy Since 14-Jul-2020
$20
$-0.01 (-0.05%)
$62
4 years 1 months 10 days ago
(02-Sep-2022)
1/4 (25%)
$0.02 (0.10%)
41
Buy Since 13-Jun-2022
$21
$0.99 (4.95%)
4 years 3 months 29 days ago
(13-Jun-2022)
0/1 (0%)
$15.82 (305.41%)
